Jordan · Delayed Price · Currency is JOD General Investment Statistics
Total Valuation
ASE:GENI has a market cap or net worth of JOD 24.50 million. The enterprise value is 23.46 million.
| Market Cap | 24.50M |
| Enterprise Value | 23.46M |
Important Dates
The next estimated earnings date is Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Apr 23, 2026 |
Share Statistics
ASE:GENI has 10.00 million shares outstanding.
| Current Share Class | 10.00M |
| Shares Outstanding | 10.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 20.41% |
| Owned by Institutions (%) | 5.98% |
| Float | 2.50M |
Valuation Ratios
The trailing PE ratio is 10.00.
| PE Ratio | 10.00 |
| Forward PE | n/a |
| PS Ratio | 1.94 |
| PB Ratio | 0.71 |
| P/TBV Ratio | 0.71 |
| P/FCF Ratio | 38.39 |
| P/OCF Ratio | 19.19 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.72, with an EV/FCF ratio of 36.76.
| EV / Earnings | 9.57 |
| EV / Sales | 1.86 |
| EV / EBITDA | 8.72 |
| EV / EBIT | 10.09 |
| EV / FCF | 36.76 |
Financial Position
The company has a current ratio of 4.20
| Current Ratio | 4.20 |
| Quick Ratio | 1.83 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 7.79% and return on invested capital (ROIC) is 5.74%.
| Return on Equity (ROE) | 7.79% |
| Return on Assets (ROA) | 4.21% |
| Return on Invested Capital (ROIC) | 5.74% |
| Return on Capital Employed (ROCE) | 6.76% |
| Weighted Average Cost of Capital (WACC) | 4.00% |
| Revenue Per Employee | 88,762 |
| Profits Per Employee | 17,255 |
| Employee Count | 142 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 1.40 |
Taxes
In the past 12 months, ASE:GENI has paid 559,760 in taxes.
| Income Tax | 559,760 |
| Effective Tax Rate | 18.60% |
Stock Price Statistics
The stock price has decreased by -16.95% in the last 52 weeks. The beta is -0.05, so ASE:GENI's price volatility has been lower than the market average.
| Beta (5Y) | -0.05 |
| 52-Week Price Change | -16.95% |
| 50-Day Moving Average | 2.79 |
| 200-Day Moving Average | 2.80 |
| Relative Strength Index (RSI) | 36.36 |
| Average Volume (20 Days) | 5,660 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASE:GENI had revenue of JOD 12.60 million and earned 2.45 million in profits. Earnings per share was 0.25.
| Revenue | 12.60M |
| Gross Profit | 5.08M |
| Operating Income | 2.32M |
| Pretax Income | 3.01M |
| Net Income | 2.45M |
| EBITDA | 2.69M |
| EBIT | 2.32M |
| Earnings Per Share (EPS) | 0.25 |
Balance Sheet
The company has 1.04 million in cash and no debt, with a net cash position of 1.04 million or 0.10 per share.
| Cash & Cash Equivalents | 1.04M |
| Total Debt | n/a |
| Net Cash | 1.04M |
| Net Cash Per Share | 0.10 |
| Equity (Book Value) | 34.37M |
| Book Value Per Share | 3.44 |
| Working Capital | 9.06M |
Cash Flow
In the last 12 months, operating cash flow was 1.28 million and capital expenditures -638,435, giving a free cash flow of 638,112.
| Operating Cash Flow | 1.28M |
| Capital Expenditures | -638,435 |
| Depreciation & Amortization | 365,365 |
| Net Borrowing | n/a |
| Free Cash Flow | 638,112 |
| FCF Per Share | 0.06 |
Margins
Gross margin is 40.29%, with operating and profit margins of 18.44% and 19.44%.
| Gross Margin | 40.29% |
| Operating Margin | 18.44% |
| Pretax Margin | 23.88% |
| Profit Margin | 19.44% |
| EBITDA Margin | 21.34% |
| EBIT Margin | 18.44% |
| FCF Margin | 5.06% |
Dividends & Yields
This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 4.90%.
| Dividend Per Share | 0.12 |
| Dividend Yield | 4.90% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 57.54% |
| Buyback Yield | n/a |
| Shareholder Yield | 4.90% |
| Earnings Yield | 10.00% |
| FCF Yield | 2.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASE:GENI has an Altman Z-Score of 7.14 and a Piotroski F-Score of 5.
| Altman Z-Score | 7.14 |
| Piotroski F-Score | 5 |